Canadian Society of Hospital Pharmacists Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2003
NCT00213200
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Canadian Society of Hospital Pharmacists

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cellulitis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6